Treatment of recalcitrant orbital inflammatory syndrome with plasmapheresis therapy

Yasaira Rodriguez Torres1, Fereshteh Azad2, Xihui Lin2

  • 1Ophthalmology, Kresge Eye Institute, Detroit, Michigan, USA yrodrigu@med.wayne.edu.

BMJ Case Reports
|January 11, 2020
PubMed

Refractory idiopathic orbital inflammation (IOI) represents a management challenge due to its significant proportion of treatment failures. Currently, there are no established guidelines for recalcitrant IOI and majority of immunosuppressive agents have resulted in variable outcomes. Advancements of plasmapheresis therapy can play a significant role in ophthalmological diseases. This treatment has shown to produce a satisfactory therapeutic response in immune-mediated neurological conditions. In this case report, we share our successful experience with the use of plasmapheresis therapy in a patient with recalcitrant IOI.

Related Concept Videos